AmacaThera Raises $3.25M in Seed Funding

Funding Rounds

▤ Summary

AmacaThera , a Toronto, Canada-based company commercializing hydrogel-based drug delivery platforms, raised CAD$3.25m in seed financing. The round was led by Sprout BioVentures, Viva Biotech, with participation from Grey Sky Venture Partners and additional investors. The company intends to use the funds to advance its drug delivery platform technology through Phase I clinical proof-of-concept. AmacaThera has developed proprietary technology to allow sustained and controllable release of diverse therapeutic agents from injectable, biocompatible hydrogels. AmacaThera’s founding technology was discovered at the University of Toronto by Dr. Molly Shoichet, a leading expert on polymer design and recent winner of the Killam Prize in Engineering.

$ Funding

$
Amount $3.3M Total raised
□
Date January 12, 2019 Announcement date
◎
Investors - Lead investors
▥
Company https://www.amacathera.ca Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies